Neuberger Berman Group LLC Has $50.31 Million Holdings in Novanta Inc. $NOVT

Neuberger Berman Group LLC decreased its position in shares of Novanta Inc. (NASDAQ:NOVT) by 2.8% in the 3rd quarter, HoldingsChannel reports. The firm owned 502,308 shares of the technology company’s stock after selling 14,606 shares during the quarter. Neuberger Berman Group LLC’s holdings in Novanta were worth $50,306,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of NOVT. Envestnet Asset Management Inc. raised its position in shares of Novanta by 15.4% in the 3rd quarter. Envestnet Asset Management Inc. now owns 81,691 shares of the technology company’s stock valued at $8,181,000 after buying an additional 10,896 shares in the last quarter. Bessemer Group Inc. lifted its holdings in shares of Novanta by 24.8% during the 3rd quarter. Bessemer Group Inc. now owns 222,391 shares of the technology company’s stock worth $22,272,000 after acquiring an additional 44,252 shares during the period. Exchange Traded Concepts LLC boosted its position in shares of Novanta by 22.1% during the 3rd quarter. Exchange Traded Concepts LLC now owns 178,375 shares of the technology company’s stock worth $17,864,000 after acquiring an additional 32,278 shares in the last quarter. Atika Capital Management LLC acquired a new stake in shares of Novanta during the 2nd quarter worth approximately $1,367,000. Finally, Congress Asset Management Co. bought a new position in Novanta in the third quarter valued at approximately $59,153,000. 98.35% of the stock is currently owned by institutional investors and hedge funds.

Novanta Stock Performance

Shares of NOVT stock opened at $131.22 on Friday. The firm has a market capitalization of $4.68 billion, a price-to-earnings ratio of 89.88 and a beta of 1.61. The company has a current ratio of 3.69, a quick ratio of 2.80 and a debt-to-equity ratio of 0.16. The business’s 50-day moving average price is $134.88 and its 200-day moving average price is $121.00. Novanta Inc. has a 12 month low of $98.27 and a 12 month high of $149.95.

Novanta (NASDAQ:NOVT) last released its quarterly earnings data on Monday, February 23rd. The technology company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.88 by $0.03. The company had revenue of $258.35 million during the quarter, compared to the consensus estimate of $260.72 million. Novanta had a return on equity of 13.12% and a net margin of 5.49%.During the same quarter in the prior year, the firm posted $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. Equities research analysts forecast that Novanta Inc. will post 3.03 EPS for the current year.

Insider Buying and Selling

In other news, CEO Matthijs Glastra sold 7,500 shares of Novanta stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $145.04, for a total transaction of $1,087,800.00. Following the transaction, the chief executive officer owned 57,367 shares in the company, valued at approximately $8,320,509.68. The trade was a 11.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Robert Buckley sold 1,423 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $140.88, for a total value of $200,472.24. Following the completion of the sale, the chief financial officer owned 93,814 shares in the company, valued at $13,216,516.32. This trade represents a 1.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 24,346 shares of company stock worth $3,382,737 over the last three months. Insiders own 1.20% of the company’s stock.

Analysts Set New Price Targets

NOVT has been the subject of several research analyst reports. Zacks Research upgraded shares of Novanta from a “strong sell” rating to a “hold” rating in a research report on Friday, January 16th. Weiss Ratings raised Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, January 20th. Finally, Robert W. Baird set a $150.00 price target on Novanta in a research note on Wednesday, February 25th. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Novanta has a consensus rating of “Hold” and an average target price of $150.00.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.